Placental Conditions With Consequences for the Fetal Brain


DEVELOPMENT OF NORMAL PLACENTAL STRUCTURE AND FUNCTION

The normal placenta is far more than a mere conduit for nutrient and waste exchange between the mother and fetus. Rather, it is a highly specialized organ with multiple complex and interrelated functions, including hormonal and trophic factor synthesis and transfer and immunological (both tolerance and barrier) functions. These complex physiological functions are served by an anatomical structure that develops rapidly (but is ultimately transient) through a complex, dynamic, and overlapping series of maturational events across different spatial and temporal dimensions. These events include the growth and differentiation of multiple cell types, placental and uterine vascular development, remodeling and adaptation, and villous development. Different forms of “placental failure” have their origins in the earliest phases of placental development, although their clinical manifestations are often delayed until later in gestation. For these reasons, an understanding of the earliest stages of placental development, both normal and abnormal, is key to understanding the origins of placental failure and its spectrum of complications, such as preeclampsia, fetal growth restriction, and placental abruption, all of which are significant risk factors for long-term adverse neurological and developmental outcomes in the offspring.

Implantation and Early Placental Development

The events around implantation and early placental development are demonstrated in Figs. 10.1A–C and Table 10.1 . Around the fifth day postconception (p/c), the blastocyst begins to develop into three distinct compartments, namely (i) an inner cell mass (embryoblast), (ii) a blastocyst cavity (blastocele), and (iii) an outer trophoblastic layer, the trophectoderm, which surrounds both the inner cell mass (polar trophoblasts) and blastocele (mural trophoblasts) (see Fig. 10.1 ). The trophectoderm layer consists of mural and polar trophoblasts (see Fig. 10.1 ); anchoring villi that attach the blastocyst to the maternal decidua (basal plate) are covered by villous trophoblasts between 6 to 8 days p/c. The blastocyst invades the decidual layer (see Fig. 10.1A ) and becomes covered by the endometrial epithelium (see Fig. 10.1B ); here it develops through most of the first trimester, being supported by fetal growth factors and proteins secreted by endometrial glands (histotrophic nutrition), independent of maternal blood and oxygen supply. Around 9 days p/c, trophoblasts begin secreting matrix metalloproteinase into the surrounding tissue, creating a primitive syncytium for supporting blastocyst development.

Figs. 10.1 A, B, C, Early placental development .

TABLE 10.1
Timeline of Early Placental Development
Data adapted from James JL, Boss AL, Sun C, et al. From stem cells to spiral arteries: a journey through early placental development. Placenta 2022;125:68–77.
TIMING EVENTS
5 pcd Onset of blastocyst development into three distinct compartments: (i) inner cell mass (embryoblast), (ii) blastocyst cavity (blastocele), and (iii) outer trophoblastic layer
6 pcd Polar trophoblast anchors the blastocyst to uterine endometrial epithelium
8 pcd Blastocyst enters the decidua and is covered by endometrial epithelium
9 pcd Trophoblasts release matrix metalloproteinase (MMP) to create a primitive syncytium for blastocyst development
12–13 pcd Primitive cytotrophoblasts invade syncytium to create primary villi; mesenchymal cells from the inner cell mass invade primary villi to form secondary villi
~15 pcd Endothelial cells (mesenchymal origin) align in the villous core
18–21 pcd Fetal capillaries appear, after which the villi are considered tertiary villi
~22 pcd Smooth muscle cells develop around fetal vessels
~30 pcd Placental villi approach mature structure
~32 pcd The umbilical cord connects placental and fetal circulations

Development of the Trophoblast Lineages and the Placental Villous Tree

Development of the trophoblast lineages and placental villous tree are illustrated in in Figs. 10.2 and 10.3 . After implantation, the trophectoderm forms the mononuclear cytotrophoblast layer that covers the entire placenta. This progenitor cytotrophoblast monolayer constitutes the primary placental stem cells and will differentiate into multiple cell lineages, starting with an outer syncytiotrophoblast layer and an inner villous cytotrophoblast layer. The multinucleated syncytiotrophoblast monolayer layer is formed by cells that fuse into a syncytium and serves a number of critical functions, including oxygen-nutrient transfer, waste removal, synthetic functions (peptide and steroid hormones), and immunological roles. The syncytiotrophoblast, with its rich array of transporter membrane proteins, plays the major role in regulating the bidirectional transfer of nutrients and waste products between the intervillous space and the villous stroma. Once in the villous stroma, small molecules such as amino acids, glucose, and electrolytes readily pass through the intercellular junctions in the fetal endothelial layer.

Fig. 10.2, Trophoblast lineage development. See also Fig. 10.3 .

Fig. 10.3, Trophoblast lineage development. Histological section of an anchoring villus from a 7.6 week of gestation placenta. Extravillous trophoblast (EVT) cell columns can be seen extending toward and invading the maternal decidua. Stb , Syncytiotrophoblast.

Villous development starts around 12 to 13 days p/c when cytotrophoblasts invade the primitive syncytium to form the primary villi , which are then infiltrated by mesenchymal cells from the inner cell mass to form secondary villi . When the mesenchymal cells form capillaries, the villi become tertiary villi (discussed later). Mesenchymal cells in the villous stroma consist of multiple cell types, including fibroblasts, smooth muscle cells, macrophages, and endothelial cells, all of which play important roles in support of villous health and development throughout gestation. These mesenchymal cells provide the necessary scaffolding and support for normal villous growth, development, and function, failure of which causes distal villous hypoplasia and failure of placental function. The villous stroma is also an important glycogen storage site, as well as a production site for substances like placental serotonin, which plays an important role in early brain development (discussed later). The villous stroma is metabolically active and, especially under conditions of increased stromal volume (e.g., maternal diabetes), may act as a metabolic “sink,” leaching available energy substrate delivery away from the fetus.

The stromal mesenchymal cells play a critical role in angiogenesis in the fetoplacental circulation. At ~15 days p/c, endothelial cells align in the villous core, becoming fetal capillaries and developing a surrounding smooth muscle layer between 18 to 21 days p/c. Around 32 days p/c the umbilical cord connects the placental and fetal circulations, although the spiral arteries remain occluded and do not perfuse the intervillous spaces until late in the first trimester (discussed later).

Extravillous Trophoblast Development

The tips of the villous trophoblast adhere to the decidual surface, anchoring the villous tree and becoming multilayered, and then give rise to extravillous trophoblasts that differentiate into two lineages and migrate into the decidua along two routes. The interstitial trophoblasts (see Fig. 10.3 ) migrate into the decidual stroma guided by maternal signaling molecules, where their primary role is to degrade and remodel the spiral artery walls. The endarterial trophoblasts (see Fig. 10.3 ) migrate directly and profusely into the lumina of spiral arteries, where they form luminal plugs for most of the first trimester, temporarily blocking premature entry of blood and oxygen into the intervillous spaces and preventing oxidative stress. Failure of normal spiral artery remodeling and luminal plugging by the extravillous trophoblasts plays a fundamental role in placentation insufficiency and underlies a number of the major obstetric syndromes , including preeclampsia, fetal growth restriction, and placental abruption, all conditions associated with significant risk for disrupted development and injury to the developing fetal brain.

In summary , the normal villous and syncytiotrophoblast populations are principally involved in development of the fetal components of the placenta, whereas the extravillous lineages (discussed later) are involved in events on the maternal side.

Development of the Uterine, Placental, and Fetal Circulations

An understanding of development of the uterine-placental-fetal vascular axis is essential to understanding the pathophysiology of such conditions as placental-based fetal growth restriction, one of the major complications of pregnancy, and one with significant perinatal and long-term neurodevelopmental risks for infants born from such pregnancies. In the next section we describe normal and abnormal maturation of the uteroplacental, fetoplacental, and fetal circulations, especially as this maturation relates to the fetus experiencing placental insufficiency.

Development of the Placental Vasculature

The placental vascular system consists of a uteroplacental (maternal) and a fetoplacental system, interfacing at the intervillous sinuses (see Fig. 10.1C ). As discussed previously, growth of the developing embryo and placenta is independent of blood and oxygen supply through much of the first trimester. This low-oxygen environment with oxygen partial pressure levels ~20 mm Hg is physiological and not hypoxic, serving a protective role against damaging reactive oxygen species during a period when embryonic and placental antioxidant systems are underdeveloped. In fact, premature opening of the spiral arteries with influx of oxygenated blood flow into the intervillous space at a time when antioxidant defenses are underdeveloped causes oxidative injury and is a major cause of spontaneous miscarriages in the late first trimester.

Development of the Uteroplacental Vasculature

The uterine vasculature extends from the uterine arteries to the ends of the spiral arteries where the uteroplacental circulation enters the intervillous spaces. Spiral artery remodeling starts when interstitial and endarterial trophoblasts enter the decidua (discussed earlier) where they work in combination to remodel the spiral arteries. This remodeling is achieved through cellular lytic, apoptotic, and dedifferentiation actions in the endothelial, muscularis, and perivascular layers of the spiral arteries, thereby transforming them into patulous, passive conduits (see Fig. 10.4A ). The increased caliber and reduced vasoconstrictive capacity of the normal remodeled spiral artery system leads to an overall decrease in uteroplacental resistance and loss of the normal diastolic dicrotic notch (discussed later; see Fig. 10.8 ). The reduction in blood flow velocity into, and transit through, the intervillous spaces thereby optimizes maternal-fetal oxygen and nutrient transfer while minimizing mechanical trauma to the villous structures. Spiral artery transformation is deepest (i.e., into the junctional zone of the myometrium) (see Fig. 10.4A ) at the center of the placenta. Failure of such “deep placentation” is seen in preeclampsia (discussed later) and is frequently associated with arterial thrombosis. The major invasion of endarterial trophoblasts into the spiral arteries occludes their lumina with villous plugs, which persist until 8 to 10 weeks gestation (discussed earlier) (see Fig. 10.1C ), after which these plugs commence a gradual breakdown. By the end of the first trimester, blood flow is established between the spiral arteries and the intervillous compartment.

Fig. 10.4, Spiral artery remodeling in the myometrial junctional zone showing (A) normal remodeling with replacement of the musculo-elastic structure by fibrinoid cytotrophoblast, (B) partial transformation, (C) absent transformation with trophoblastic giant cells around the arteries, and (D) absent transformation with acute atherosis and intimal hyperplasia (PAS staining to highlight fibrinoid).

Fig. 10.8, Diagram of uterine artery Doppler waveform showing the normal diastolic dicrotic notch, which is lost when spiral artery remodeling proceeds normally but persists in primary placental failure, especially when associated with preeclampsia .

Remodeling of larger uterine arteries during the first 20 weeks of gestation results in a two-fold increase in their diameter. This progressive vasodilation of the larger uterine blood vessels is trophoblast-independent and mediated by substances such as progesterone, estrogen, placental growth factor, human chorionic gonadotrophin, endothelial nitric oxide, and vascular endothelial growth factor. In contrast to the remodeled spiral arteries, which decrease blood flow velocity into the intervillous space, the larger upstream arteries regulate volumetric blood flow into the intervillous system. Disturbances in radial artery adaptation have been implicated in later pregnancy disorders, such as preeclampsia and placental abruption.

Development of the Fetoplacental Vasculature ( Fig. 10.5 )

The fundamental structure of the fetoplacental vascular tree is formed over the first 6 gestational weeks (GW), followed by phases of rapid branching angiogenesis (between 6 to 24 GW) and nonbranching angiogenesis (after 24 GW), both supported by the mesenchymal stromal cells (see Fig. 10.5 ). Conditions like placental failure with fetal growth restriction (discussed later) are in part due to impaired angiogenesis in early gestation, resulting in decreased vascular branching, vascular volume, and exchange capacity, as well as increased resistance to blood flow.

Fig. 10.5, Late gestation villi and the relationship between microvasculature, syncytiotrophoblast, mesenchymal stroma, and the vasculo-syncytial membrane.

The Maternal-Fetal Circulatory Interface

The vasculosyncytial membrane consists of the syncytiotrophoblast layer and fetal capillary endothelium and abuts the intervillous space; that is, the terminal extent of maternal-placental perfusion (see Figs. 10.5 and 10.6 ). The syncytiotrophoblast has two polarized plasma membranes, the maternal-facing apical microvillous plasma membrane and the fetal-facing basal plasma membrane. The so-called interhemal barrier between maternal blood in the intervillous spaces and the fetal blood in the villous capillaries consists of the two syncytiotrophoblast membranes, basement membranes, stromal villous mesenchymal tissues, and the capillary endothelium (see Fig. 10.5 ). The interhemal barrier determines the efficiency of placental transfer, primarily through its overall surface area and its thickness. At ~32 weeks GA the interhemal barrier simplifies to a two-layered vasculosyncytial membrane, thereby decreasing its thickness and bringing the maternal and fetal circulations into closer proximity, enhancing oxygen-nutrient transfer during the major increase in late gestational fetal demand. Placental pathologies, such as distal villous hypoplasia, infarcts, or avascular villi, will decrease the effective total surface area of the interhemal barrier, whereas others, such as maternal diabetes with delayed villous maturation, and hydrops fetalis with villous edema, will increase its thickness and thereby the diffusion distance.

Fig. 10.6, Diagram of maternal and fetal compartments of the placenta, the terminal villi, and intervillous spaces .

Development of the Fetal Circulation

The fetal circulation has lower oxygen content than that of the newborn, but the fetus is not hypoxic. In fact, the fetus has a considerable intrinsic margin of safety for oxygen, because its supply exceeds its requirements owing to factors such as generous blood flow to the fetal tissues and enhanced oxygen binding with fetal hemoglobin. Furthermore, the fetal brain is privileged in receiving the highest regional oxygen supply, through the anatomical and physiological arrangement of the fetal circulation .

Distribution of Fetal Blood Flow

Unlike the postnatal circulatory system, that of the fetus consists of two arterial circulations operating in parallel and connected by intra- and extracardiac shunts, the patency of which is critical for normal fetal development (see Fig. 10.7 ). The primary connection between the two fetal arterial systems is at the aortic isthmus, which is the circulatory watershed between the more oxygenated brain–upper body circulation (supplied by the left ventricle) and that of the less oxygenated subdiaphragmatic tissues and placenta (supplied by the right ventricle via the ductus arteriosus). The normal streaming of ductus arteriosus flow in the fetus results from the resistance differential between pulmonary (high resistance) and placental (low resistance) circulations. In normal circumstances, this arrangement provides preferential oxygen-substrate delivery to the aorta and the developing brain . Prior to 32 GW the placenta receives about one-third of the cardiac output, decreasing to one quarter across the rest of gestation. Conversely, placental insufficiency in conditions such as fetal growth restriction and preeclampsia leads to changes in vascular resistance in the two circulations, altering the volume and oxygen-substrate content of perfusion delivered through the fetal shunts. Superimposed upon these pathophysiologic changes are compensatory responses aimed at sustaining the developing brain’s privileged oxygen supply, achieved through hypoxemic vasodilation and reduction of the cerebral vascular resistance. These compensatory responses are capable of maintaining cerebral oxygenation for long periods of mild-to-moderate hypoxemia.

Fig. 10.7, The normal fetal circulation with circulating oxygen levels indicated by the color scheme (high, medium, and low) .

Distribution of Fetal Oxygenation

The umbilical vein has the highest blood oxygen content in the fetus, with normal oxyhemoglobin saturation around 85% to 90%. To minimize oxygen-nutrient extraction en route to the brain, about half the umbilical vein blood flow bypasses the liver through the ductus venosus into the right atrium and across the foramen ovale to the left heart and aorta (see Fig. 10.7 ). Consequently, the oxyhemoglobin saturation of the cerebral arterial circulation is approximately 65%, whereas that in the descending aorta (from the right ventricle and ductus arteriosus) is between 50% to 55%. In placental failure there are significant changes in regional fetal blood flow and oxygen distribution (discussed later).

Fetal Myocardial Function

Compared with that of the term newborn, the fetal myocardium is limited in both its systolic and diastolic function. Specifically, the fetal myocardial response to stretch generates lower active tension, thereby limiting systolic function, whereas decreased diastolic relaxation results in higher resting tension and reduced diastolic filling, thereby limiting diastolic performance. Although the fetal myocardium follows the basic Frank-Starling model, fetal cardiac output is more dependent on heart rate than that of the normal term newborn. Furthermore, autonomic innervation of the fetal heart, especially sympathetic function, is immature and limited .

Normal Development of Placental Function

The placenta serves many functions critical to the maintenance of normal pregnancy (see Box 10.1 ). In addition to nutrient and waste exchange, these functions include the synthesis and transfer of hormones and trophic factors, complex signaling between fetus and mother, regulation of inflammatory pathways, and immune functions, both barrier and tolerance. Transfer functions across the placenta required for these various roles include passive diffusion, facilitated diffusion, active transport, endocytosis, and exocytosis. In general, with advancing gestation the efficacy of placental transfer increases as the fetal growth rate increases .

BOX 10.1
Overview of Normal Placental Functions

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here